Experimental lung carcinogenic in vivo study of aflatoxin G1 in NIH mice.
- Author:
Xiang-Hua HUANG
1
;
Xiang-Hong ZHANG
;
Yue-Hong LI
;
Jun-Ling WANG
;
Xia YAN
;
Ling-Xiao XING
;
Feng-Rong WANG
Author Information
- Publication Type:Journal Article
- MeSH: Adenocarcinoma; chemically induced; pathology; Aflatoxins; toxicity; Animals; Aspergillus flavus; Carcinogens; toxicity; Lung Neoplasms; chemically induced; pathology; Mice; Random Allocation
- From: Chinese Journal of Pathology 2004;33(3):260-263
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEAflatoxin G1 (AFG1) is a member of the carcinogenic aflatoxin family produced by aspergillus flavus. It is a major contaminating mycotoxin in food in areas of China with high cancer incidence. The purpose of this study is to explore the carcinogenic effects of AFG1 in NIH mice.
METHODSNIH mice were randomly divided into three groups. Two experimental groups were treated intragastrically by gavage with AFG1 3 microg/kg and AFG1 30 microg/kg respectively, 3 times a week for 24 weeks. The control group was treated with normal saline. All mice were fed with food that was free of AFGs as confirmed by HPLC analysis. The mice were weighed every week throughout the entire experiment, and then sacrificed and examined pathologically at the 58th and 74th weeks respectively.
RESULTSCompared with control mice receiving no AFG1, bronchial epithelial hyperplasia, alveolar hyperplasia and adenocarcinoma of lung were observed in mice receiving AFG1 treatment. The incidences of bronchial epithelial hyperplasia, alveolar hyperplasia and adenocarcinoma of lung were 60.0%, 10.0% and 30.0% for mice receiving 3 microg/kg AFG1 and 28.6%, 35.7%, 42.9% for mice receiving 30 microg/kg of the toxin, respectively.
CONCLUSIONOral administration of AFG1 can induce hyperplastic lesions and adenocarcinoma of lung in NIH mice.